Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Springer Timothy A, Director. Insider active across 4 companies, notably Morphic Holding, Inc.. Aggregated, 36 filings have been logged. Breakdown: 22 buys · 0 sell. Total volume traded: €91.7m. Activity tracked since 21 May 2021. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Springer Timothy A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24,785.081 shares@ US$403.468520.7% of flowSeries A Convertible Preferred StockSEC:0001453687-23-000087:0
25 of 36 declarations
About Springer Timothy A
SPRINGER TIMOTHY A is a Director and has filed 36 filings in total. Across the 36 sampled filings, the transactions are all acquisitions, with a total reported volume of EUR 91686332, and the sampled filings run from 2021-05-25 to 2026-01-06. The largest sampled filings concern Morphic Holding, Inc., Cartesian Therapeutics, Inc., Selecta Biosciences INC, and Tectonic Therapeutic, Inc.